vs

Side-by-side financial comparison of AbbVie (ABBV) and Ingram Micro Holding Corp (INGM). Click either name above to swap in a different company.

AbbVie is the larger business by last-quarter revenue ($15.0B vs $14.0B, roughly 1.1× Ingram Micro Holding Corp). AbbVie runs the higher net margin — 4.6% vs 0.7%, a 3.9% gap on every dollar of revenue. On growth, Ingram Micro Holding Corp posted the faster year-over-year revenue change (13.7% vs 9.9%). Over the past eight quarters, Ingram Micro Holding Corp's revenue compounded faster (11.0% CAGR vs 1.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Ingram Micro Holding Corporation is an American distributor of information technology products and services. The company is based in Irvine, California, U.S. and has operations around the world. Founded as Micro D, Inc in 1979 in California by Geza Czige and Lorraine Mecca, the company, originally a traditional distributor focused on marketing, selling and shipping vendor products to resellers, is currently specializing on becoming a platform-based business that focuses on its digital experie...

ABBV vs INGM — Head-to-Head

Bigger by revenue
ABBV
ABBV
1.1× larger
ABBV
$15.0B
$14.0B
INGM
Growing faster (revenue YoY)
INGM
INGM
+3.8% gap
INGM
13.7%
9.9%
ABBV
Higher net margin
ABBV
ABBV
3.9% more per $
ABBV
4.6%
0.7%
INGM
Faster 2-yr revenue CAGR
INGM
INGM
Annualised
INGM
11.0%
1.8%
ABBV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ABBV
ABBV
INGM
INGM
Revenue
$15.0B
$14.0B
Net Profit
$697.0M
$98.9M
Gross Margin
6.6%
Operating Margin
26.6%
1.6%
Net Margin
4.6%
0.7%
Revenue YoY
9.9%
13.7%
Net Profit YoY
-46.0%
42.9%
EPS (diluted)
$0.39
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
INGM
INGM
Q1 26
$15.0B
$14.0B
Q4 25
$16.6B
$14.9B
Q3 25
$15.8B
$12.6B
Q2 25
$15.4B
$12.8B
Q1 25
$13.3B
$12.3B
Q4 24
$15.1B
Q3 24
$14.5B
$11.8B
Q2 24
$14.5B
$11.5B
Net Profit
ABBV
ABBV
INGM
INGM
Q1 26
$697.0M
$98.9M
Q4 25
$1.8B
$121.4M
Q3 25
$186.0M
$99.5M
Q2 25
$938.0M
$37.8M
Q1 25
$1.3B
$69.2M
Q4 24
$-22.0M
Q3 24
$1.6B
$77.0M
Q2 24
$1.4B
$54.6M
Gross Margin
ABBV
ABBV
INGM
INGM
Q1 26
6.6%
Q4 25
72.6%
6.5%
Q3 25
66.4%
6.9%
Q2 25
71.8%
6.6%
Q1 25
70.0%
6.7%
Q4 24
70.9%
Q3 24
70.9%
7.2%
Q2 24
70.9%
7.2%
Operating Margin
ABBV
ABBV
INGM
INGM
Q1 26
26.6%
1.6%
Q4 25
27.3%
2.1%
Q3 25
12.1%
1.8%
Q2 25
31.7%
1.1%
Q1 25
28.0%
1.6%
Q4 24
-9.9%
Q3 24
26.5%
1.9%
Q2 24
27.6%
1.6%
Net Margin
ABBV
ABBV
INGM
INGM
Q1 26
4.6%
0.7%
Q4 25
10.9%
0.8%
Q3 25
1.2%
0.8%
Q2 25
6.1%
0.3%
Q1 25
9.6%
0.6%
Q4 24
-0.1%
Q3 24
10.8%
0.7%
Q2 24
9.5%
0.5%
EPS (diluted)
ABBV
ABBV
INGM
INGM
Q1 26
$0.39
$0.68
Q4 25
$1.02
$0.52
Q3 25
$0.10
$0.42
Q2 25
$0.52
$0.16
Q1 25
$0.72
$0.29
Q4 24
$-0.03
Q3 24
$0.88
$0.35
Q2 24
$0.77
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
INGM
INGM
Cash + ST InvestmentsLiquidity on hand
$916.0M
Total DebtLower is stronger
$3.3B
Stockholders' EquityBook value
$4.2B
Total Assets
$20.9B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
INGM
INGM
Q1 26
$916.0M
Q4 25
$5.3B
$1.9B
Q3 25
$5.7B
$802.6M
Q2 25
$6.5B
$856.7M
Q1 25
$5.2B
$881.6M
Q4 24
$5.6B
Q3 24
$7.3B
$849.5M
Q2 24
$13.2B
Total Debt
ABBV
ABBV
INGM
INGM
Q1 26
$3.3B
Q4 25
$58.9B
$3.2B
Q3 25
$63.0B
$3.8B
Q2 25
$63.0B
$3.7B
Q1 25
$64.5B
$3.5B
Q4 24
$60.3B
Q3 24
$58.5B
$3.8B
Q2 24
$58.0B
Stockholders' Equity
ABBV
ABBV
INGM
INGM
Q1 26
$4.2B
Q4 25
$-3.3B
$4.2B
Q3 25
$-2.6B
$4.1B
Q2 25
$-183.0M
$4.0B
Q1 25
$1.4B
$3.9B
Q4 24
$3.3B
Q3 24
$6.0B
$3.6B
Q2 24
$6.8B
$3.5B
Total Assets
ABBV
ABBV
INGM
INGM
Q1 26
$20.9B
Q4 25
$134.0B
$21.2B
Q3 25
$133.9B
$19.2B
Q2 25
$137.2B
$19.5B
Q1 25
$136.2B
$18.6B
Q4 24
$135.2B
Q3 24
$143.4B
$18.6B
Q2 24
$141.9B
Debt / Equity
ABBV
ABBV
INGM
INGM
Q1 26
0.79×
Q4 25
0.75×
Q3 25
0.93×
Q2 25
0.92×
Q1 25
45.44×
0.90×
Q4 24
18.15×
Q3 24
9.70×
1.06×
Q2 24
8.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
INGM
INGM
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-962.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$53.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
INGM
INGM
Q1 26
Q4 25
$5.2B
$1.6B
Q3 25
$7.0B
$-146.0M
Q2 25
$5.2B
$-298.0M
Q1 25
$1.6B
$-200.4M
Q4 24
$7.0B
Q3 24
$5.4B
$-277.0M
Q2 24
$2.3B
Free Cash Flow
ABBV
ABBV
INGM
INGM
Q1 26
$-962.3M
Q4 25
$4.9B
$1.5B
Q3 25
$6.6B
$-175.0M
Q2 25
$4.9B
$-333.2M
Q1 25
$1.4B
$-230.2M
Q4 24
$6.8B
Q3 24
$5.2B
$-315.0M
Q2 24
$2.0B
FCF Margin
ABBV
ABBV
INGM
INGM
Q1 26
-6.9%
Q4 25
29.4%
10.2%
Q3 25
42.1%
-1.4%
Q2 25
31.7%
-2.6%
Q1 25
10.5%
-1.9%
Q4 24
44.7%
Q3 24
35.9%
-2.7%
Q2 24
14.0%
Capex Intensity
ABBV
ABBV
INGM
INGM
Q1 26
0.3%
Q4 25
2.0%
0.2%
Q3 25
2.4%
0.2%
Q2 25
1.7%
0.3%
Q1 25
1.8%
0.2%
Q4 24
1.9%
Q3 24
1.7%
0.3%
Q2 24
1.7%
Cash Conversion
ABBV
ABBV
INGM
INGM
Q1 26
Q4 25
2.87×
12.85×
Q3 25
37.76×
-1.47×
Q2 25
5.49×
-7.88×
Q1 25
1.27×
-2.90×
Q4 24
Q3 24
3.49×
-3.60×
Q2 24
1.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons